drugset / Trial / NCT00307632
An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the contraceptive efficacy, safety, cycle control, compliance, and subject satisfaction of the transdermal contraceptive system, norelgestromine and ethinyl estradiol (NLGM / EE).
Timeline
- Start
- 2003-02
- Primary completion
- 2004-12
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norelgestromine | Unknown | 150 ug | Other |
| Subject | ethinyl estradiol | Small molecule | 20 ug | Other |
Indications
No indication recorded.